Regional Decreases in α‐[3H]Amino‐3‐Hydroxy‐5‐Methylisoxazole‐4‐Propionic Acid ([3H]AMPA) and 6‐[3H]Cyano‐7‐Nitroquinoxaline‐2,3‐dione ([3H]CNQX) Binding in Response to Chronic Low‐Level Lead Exposure: Reversal Versus Potentiation by Chronic Dopamine Agonist Treatment

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Journal of Neurochemistry

• Publication date

  1997-12-01

• Fields of study

  Medicine, Chemistry, Environmental Science

• Identifiers
  DOI 10.1046/j.1471-4159.1997.69062466.xPMID 9375679
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lead-induced changes in NMDA receptor complex binding: correlations with learning accuracy and with sensitivity to learning impairments caused by MK-801 and NMDA administration.

  1997cited by this paper
• Time Course and Regional Basis of Pb‐Induced Changes in MK‐801 Binding: Reversal by Chronic Treatment with the Dopamine Agonist Apomorphine but Not the D1 Agonist SKF‐82958

  1997cited by this paper
• Activation of Glutamatergic Neurotransmission by Ketamine: A Novel Step in the Pathway from NMDA Receptor Blockade to Dopaminergic and Cognitive Disruptions Associated with the Prefrontal Cortex

  1997influential reference
• Effects of typical and atypical antipsychotics on AMPA site binding

  1996cited by this paper
• Effects of a centrally active benzoylpyrrolidine drug on AMPA receptor kinetics.

  1996cited by this paper
• AMPA antagonists differ from NMDA antagonists in their effects on operant DRL and delayed matching to position tasks

  1996cited by this paper
• Preferential Vulnerability of Nucleus Accumbens Dopamine Binding Sites to Low‐Level Lead Exposure: Time Course of Effects and Interactions with Chronic Dopamine Agonist Treatments

  1996cited by this paper
• Glutamate receptor regulation of rat nucleus accumbens neurons in vivo

  1996cited by this paper
• Chronic treatment with typical and atypical antipsychotics increases the AMPA-preferring form of AMPA receptor in rat brain.

  1996cited by this paper
• Lead-induced changes in dopamine D1 sensitivity: modulation by drug discrimination training.

  1996cited by this paper
• New developments in the molecular pharmacology of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate and kainate receptors.

  1996cited by this paper
• Pb2+ reduces the current from NMDA receptors expressed in Xenopus oocytes

  1995cited by this paper
• Regulation of glutamate efflux by excitatory amino acid receptors: evidence for tonic inhibitory and phasic excitatory regulation.

  1995cited by this paper
• Biochemical evidence of an interaction of lead at the zinc allosteric sites of the NMDA receptor complex: effects of neuronal development.

  1995cited by this paper
• Region-specific alterations in dopamine and serotonin metabolism in brains of rats exposed to low levels of lead.

  1995cited by this paper
• Low Level Lead Exposure Decreases In Vivo Release of Dopamine in the Rat Nucleus Accumbens: A Microdialysis Study

  1995cited by this paper
• Developmental changes in alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor properties and expression in the rat hippocampal formation.

  1995cited by this paper
• Effect of thiocyanate on AMPA receptor mediated responses in excised patches and hippocampal slices.

  1995cited by this paper
• Relationships between lead-induced learning impairments and changes in dopaminergic, cholinergic, and glutamatergic neurotransmitter system functions.

  1995cited by this paper
• Review: neurotransmitter receptors. II. AMPA and kainate receptors.

  1995cited by this paper
• Molecular biology of glutamate receptors.

  1994cited by this paper
• Neurochemical aspects of hippocampal and cortical Pb2+ neurotoxicity.

  1994cited by this paper
• Molecular biology of glutamate receptors. Potentiation of N-methyl-D-aspartate receptor splice variants by zinc.

  1994cited by this paper
• Receptor affinities of aporphine enantiomers in rat brain tissue.

  1994cited by this paper
• AMPA Receptor Development in Rat Telencephalon: [3H]AMPA Binding and Western Blot Studies

  1994cited by this paper
• Glutamatergic Control of Dopamine Release During Stress in the Rat Prefrontal Cortex

  1994cited by this paper
• Dopamine receptor pharmacology.

  1994cited by this paper
• Heterogeneous distribution of dopamine D1 and D2 receptors in the human ventral striatum.

  1993cited by this paper
• Thiocyanate equally increases affinity for two DL-alpha-amino-3-hydroxy-5-methylisoxazolepropionic acid (AMPA) receptor states.

  1993cited by this paper
• Pb2+ modulates the NMDA-receptor-channel complex

  1993cited by this paper
• Zinc modulation of drug binding, cocaine affinity states, and dopamine uptake on the dopamine uptake complex.

  1993cited by this paper
• The effects of lead exposure on learning in a multiple repeated acquisition and performance schedule.

  1993cited by this paper
• Age-dependent effects of lead on [3H]MK-801 binding to the NMDA receptor-gated ionophore: in vitro and in vivo studies.

  1992cited by this paper
• Developmental change of the inhibition by lead of NMDA-activated currents in cultured hippocampal neurons.

  1992cited by this paper
• Dopaminergic Modulation of Glutamate Release in Striatum as Measured by Microdialysis

  1992cited by this paper
• Localization of striatal excitatory amino acid binding site subtypes to striatonigral projection neurons.

  1992cited by this paper
• Multiple states of rat brain (RS)-alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors as revealed by quantitative autoradiography.

  1992cited by this paper
• Specific role of N-acetyl-aspartyl-glutamate in the in vivo regulation of dopamine release from dendrites and nerve terminals of nigrostriatal dopaminergic neurons in the cat.

  1991cited by this paper
• Low-level lead exposure and children's cognitive function in the preschool years.

  1991cited by this paper
• Synthesis and dopamine receptor affinities of enantiomers of 2-substituted apomorphines and their N-n-propyl analogues.

  1990cited by this paper
• Autoradiographic Characterization and Localization of Quisqualate Binding Sites in Rat Brain Using the Antagonist [3H]6‐Cyano‐7‐Nitroquinoxaline‐2,3‐Dione: Comparison with (R,S)‐[3H]α‐Amino‐3‐Hydroxy‐5‐Methyl‐4‐Isoxazolepropionic Acid Binding Sites

  1990cited by this paper
• Glutamate Receptors of a Quisqualate‐Kainate Subtype are Involved in the Presynaptic Regulation of Dopamine Release in the Cat Caudate Nucleus in vivo

  1990cited by this paper
• Dopamine receptor agonists: selectivity and dopamine D1 receptor efficacy.

  1990cited by this paper
• Selective blockade of NMDA‐activated channel currents may be implicated in learning deficits caused by lead

  1990cited by this paper
• Mobilization of lead over the course of DMSA chelation therapy and long-term efficacy.

  1988cited by this paper
• Release-regulating D-2 dopamine receptors are located on striatal glutamatergic nerve terminals.

  1988cited by this paper
• Thiocyanate stabilizes AMPA binding to the quisqualate receptor.

  1988cited by this paper
• Mobilization and redistribution of lead over the course of calcium disodium ethylenediamine tetraacetate chelation therapy.

  1987cited by this paper
• Comparative distribution of dopamine D‐1 and D‐2 receptors in the basal ganglia of turtles, pigeons, rats, cats, and monkeys

  1987cited by this paper
• Longitudinal analyses of prenatal and postnatal lead exposure and early cognitive development.

  1987cited by this paper
• Prolonged lead exposure and fixed ratio performance.

  1986cited by this paper
• Performance and exposure indices of rats exposed to low concentrations of lead.

  1985cited by this paper
• Chronic low-lead exposure from birth produces deficits in discrimination reversal in monkeys.

  1985cited by this paper
• THE MORPHOLOGICAL EFFECTS OF LEAD ON THE DEVELOPING CENTRAL NERVOUS SYSTEM

  1983cited by this paper
• Modulation of striatal [3H]-glutamic acid release by dopaminergic drugs.

  1980cited by this paper
• Dopamine auto- and postsynaptic receptors: electrophysiological evidence for differential sensitivity to dopamine agonists.

  1979cited by this paper
• Molecular biology.

  1977cited by this paper
• The use of animal models for comparative studies of lead poisoning.

  1973cited by this paper

• Nonessential metals and their brain pathology

  2020cites this paper
• Caffeine-dependent stimulus-triggered oscillations in the CA3 region of hippocampal slices from rats chronically exposed to lead.

  2004cites this paper
• Glutamate and dopamine in nucleus accumbens core and shell: sequence learning versus performance.

  2003cites this paper
• Lead neurotoxicity in children: basic mechanisms and clinical correlates.

  2003cites this paper
• Molecular Mechanisms of Low-Level Pb 2+ Neurotoxicity

  2002cites this paper
• Lead and conditioned fear to contextual and discrete cues.

  2002cites this paper
• Lead and spatial vs. cued open field performance.

  2002cites this paper
• Effects of developmental lead exposure on inhibitory avoidance learning and glutamate receptors in rats.

  2001cites this paper
• Molecular changes in glutamatergic synapses induced by Pb2+: association with deficits of LTP and spatial learning.

  2001cites this paper
• Impairment of the Ca2+-permeable AMPA/kainate receptors by lead exposure in organotypic rat hippocampal slice cultures.

  2000cites this paper
• Antipsychotic drug regulation of AMPA receptor affinity states and GluR1, GluR2 splice variant expression

  1998cites this paper
• Nucleus accumbens dopaminergic medication of fixed interval schedule-controlled behavior and its modulation by low-level lead exposure.

  1998cites this paper
• Susceptibility of adult rats to lead-induced changes in NMDA receptor complex function.

  1997cites this paper
• R E V I E W A R T I C L E Lead neurotoxicity in children: basic mechanisms and clinical correlates

  year unknowncites this paper